4891 SB (Requip 0.5 mg)
Generic Name: ropinirole
Pill with imprint 4891 SB is Yellow, Five-sided and has been identified as Requip 0.5 mg. It is supplied by GlaxoSmithKline.
Requip is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Requip 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 4891 SB
Requip
- Generic Name
- ropinirole
- Imprint
- 4891 SB
- Strength
- 0.5 mg
- Color
- Yellow
- Size
- 8.00 mm
- Shape
- Five-sided
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
hypromellose 2910 (6 mPa.s),
polyethylene glycol 400,
titanium dioxide,
ferric oxide yellow,
ferric oxide red,
indigotindisulfonate sodium,
FD&C Blue No. 2,
aluminum oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00007-4891 | GlaxoSmithKline |
| 35356-0523 | Lake Erie Medical and Surgical Supply (repackager) |
More about Requip (ropinirole)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- En Español
- 111 Reviews
- Generic Availability
- Drug class: dopaminergic antiparkinsonism agents
- FDA Alerts (1)
Consumer resources
- Other brands
- Requip XL
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.